Answer
Not necessarily. An oral lead-in may be chosen to assess tolerability, or treatment may proceed directly to injections.
Sources for this answer
- Apretude 600 mg prolonged-release suspension for injection — Current selected SmPCemc · Summary of Product Characteristics
- Apretude 30 mg film-coated tablets — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.